CSIMarket
 
Ekimas Corp  (ASNB)
Other Ticker:  
 
 
Price: $0.0330 $-0.00 -12.000%
Day's High: $0.035 Week Perf: 50 %
Day's Low: $ 0.03 30 Day Perf: 29.41 %
Volume (M): 7 52 Wk High: $ 0.07
Volume (M$): $ 0 52 Wk Avg: $0.03
Open: $0.04 52 Wk Low: $0.01



 Market Capitalization (Millions $) 1
 Shares Outstanding (Millions) 28
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 5
 Cash Flow (TTM) (Millions $) -11
 Capital Exp. (TTM) (Millions $) 0

Ekimas Corp


   ASNB is expected to report next financial results on July 15, 2022.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Lazuriton Nano Biotechnology u s a Inc

Lazuriton Nano Biotechnology U S A Inc announced most recent fiscal period operating loss of $-0.010818 millions

Lazuriton Nano Biotechnology U S A Inc announced operating deficit of $-0.010818 millions, in the most recent fiscal period, an advancement from the operating loss of $-0.017245 millions, recorded in the same quarter a year ago.


Major League Football Inc

Major League Football Inc announced first quarter of 2021 operating loss of $-0.41521 millions

Major League Football Inc announced operating shortfall of $-0.41521 millions, in the first quarter of 2021, a change from the operating shortfall of $-0.119365 millions, recorded in the same quarter a year ago.


Nami Corp

Sales and Earnings Unchanged

Nami Corp announced operating shortfall of $-0.023959 millions, in the fiscal time frame ending Sep 30 2020, an advancement from the operating shortfall of $-0.282416 millions, recorded in the same quarter a year ago.


Pharma bio Serv Inc

Profits Soar by 101.69 %, Revenues Unchanged

For the financial period ending Jul 31 2021 Pharma Bio Serv Inc earnings per share more than doubled by 101.69 % at $0.10 per share, compared to results of $0.05 per share a year ago quarter, In the previous quarter company realized $0.01 per share.

Sales decreased by -1.07% from $5.04 millions in preceding quarter, eps more than doubled by 880 % from $0.01 per share.

Pharmacyte Biotech Inc

Losses Widen but Revenues Unchanged

In the most recent fiscal period Pharmacyte Biotech Inc increased losses of $-0.64 per share compared to $0.00 a year ago and from $-0.00 per share from the previous quarter.

Pharmacyte Biotech Inc reported operating shortfall of $-1.023351 millions, in the most recent fiscal period, a deterioration from the operating shortfall of $-0.881676 millions, realized in first quarter of 2020






 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AEHR's Profile

Stock Price

AEHR's Financials

Business Description

Fundamentals

Charts & Quotes

AEHR's News

Suppliers

AEHR's Competitors

Customers & Markets

Economic Indicators

AEHR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071